Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

NZ798584BActive Publication Date: 2026-09-29INHIBRX BIOSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ798584
Authority / Receiving Office
NZ · NZ
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-04-11
Filing Date
2018-04-11
Publication Date
2026-09-29
Estimated Expiration
2038-04-11

Smart Images

  • Figure 00000147_0000
    Figure 00000147_0000
  • Figure 00000148_0000
    Figure 00000148_0000
  • Figure 00000149_0000
    Figure 00000149_0000
Patent Text Reader

Abstract

The disclosure relates generally to multispecific polypeptides having constrained CD3 binding. In some embodiments, the multispecific polypeptides contain cleavable linkers that, when cleaved, results in dual effector functions. Also provided are methods of making and using these multispecific polypeptides in a variety of therapeutic, diagnostic and prophylactic indications.
Need to check novelty before this filing date? Find Prior Art